Debbie Farson

Title: The Innovative Contributions of Debbie Farson

Introduction

Debbie Farson is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of methods for expressing recombinant proteins. Her work has implications for various applications in medicine and research.

Latest Patents

Debbie Farson holds 1 patent titled "Methods to express recombinant proteins from lentiviral vectors." This patent describes lentivector constructs that facilitate the expression of recombinant proteins, polypeptides, or fragments thereof. The lentivectors feature a self-processing cleavage sequence that allows for the expression of functional proteins under the control of a single promoter. Additionally, these constructs may include a proteolytic cleavage sequence to remove the self-processing sequence from the expressed protein, enhancing the production of biologically active proteins, such as immunoglobulins, both in vitro and in vivo.

Career Highlights

Debbie Farson is currently associated with Biosante Pharmaceuticals, Inc., where she continues to advance her research and innovations. Her expertise in recombinant protein expression has positioned her as a valuable asset in the biotechnology sector.

Collaborations

Throughout her career, Debbie has collaborated with notable colleagues, including Jianmin Fang and Andrew Simmons. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Debbie Farson's innovative work in the field of biotechnology, particularly in recombinant protein expression, showcases her significant contributions to science and medicine. Her patent and collaborations reflect her commitment to advancing biotechnological applications for enhanced protein production.